Company has $66.4M in cash or $5.5 per share with almost no liabilities. Company is continuing with its projects and as biopharmaceutical company has huge potential. They have resources to continue with the development until completion. Looks like on friday it was overreaction. right now traders are trying to buy shares from weak hands (still exist) at atractive prices, but soon more and more investors will understand that company worth mucu more than $10 per share.
Oh my! how astute! words such as, "save their ass," or, "dark clouds," "lame PR hype," "a cheap inflatable device," you pull numbers out of the air, much like what is between your ears. I know that you are hoping to boost your short position, but if you shorted at 10 or 11, then you sir, are a moron. NEXT!